Nevertheless, the physiological effects (assessed under normal conditions) of Rhy on molecular/cellular targets such as ERK/MAPK, NF-κB (and TLR), or D2 receptors should be characterized in the CNS, given that effects have only been described in the context of neurotoxicity, inflammation or epilepsy. The gene discussed is MAPK1; the disease is epilepsy.